Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 629507, 10 pages
http://dx.doi.org/10.1155/2014/629507
Research Article

GSK-3β Inhibition Attenuates CLP-Induced Liver Injury by Reducing Inflammation and Hepatic Cell Apoptosis

1Department of Clinical Laboratory, Hubei Maternal and Child Health Hospital, Wuhan 430070, China
2Department of Infectious Diseases, Wuhan General Hospital of Guangzhou Military Command, Wuhan 430070, China
3Department of Pathophysiology, Anhui Medical University, Hefei 230032, China
4Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan 430030, China
5Department of Molecular Medical Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
6Experimental Transplantation Surgery, Department of General, Visceral and Vascular Surgery, University Hospital of Jena, Friedrich-Schiller-University Jena, 07747 Jena, Germany

Received 11 July 2014; Accepted 25 October 2014; Published 30 November 2014

Academic Editor: Vera L. Petricevich

Copyright © 2014 Hui Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hui Zhang, Wenjie Wang, Haoshu Fang, et al., “GSK-3β Inhibition Attenuates CLP-Induced Liver Injury by Reducing Inflammation and Hepatic Cell Apoptosis,” Mediators of Inflammation, vol. 2014, Article ID 629507, 10 pages, 2014. doi:10.1155/2014/629507